{"acadYear": "2020/2021", "description": "Advanced therapies, covering the scope of cellular, tissue and gene treatment modalities, is a rapidly advancing field that offers exciting new therapeutic possibilities and constantly challenges the regulatory environment to expedite access to these innovations.\n\nThis 4-credit module provides a better understanding of the various frameworks and practices regulating advanced therapies, including requirements for product evaluation and dossier submission for an effective product life cycle management. The module will interest students who are keen in global trending regulatory approaches and strengthening the skillsets to accommodate new innovation. There is also a focus on promoting convergences of regulatory approaches for advanced therapies.", "title": "Regulation of Cell, Tissue and Gene Therapies", "department": "Duke-NUS Dean's Office", "faculty": "Duke-NUS Medical School", "workload": [2, 2, 0, 2, 4], "moduleCredit": "4", "moduleCode": "GMS5103", "attributes": {"ssgf": true}, "semesterData": [{"semester": 2, "timetable": [], "covidZones": []}]}